108 related articles for article (PubMed ID: 8507543)
1. The expression and biological activity of IL-2 receptor on a human pancreas cancer cell line.
Kawami H; Yoshida K; Yamaguchi Y; Saeki T; Toge T
Biotherapy; 1993; 6(1):33-9. PubMed ID: 8507543
[TBL] [Abstract][Full Text] [Related]
2. Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptor.
Kanakura Y; Sugahara H; Mitsui H; Ikeda H; Furitsu T; Yagura H; Kitayama H; Kanayama Y; Matsuzawa Y
Cancer Res; 1993 Feb; 53(3):675-80. PubMed ID: 8425202
[TBL] [Abstract][Full Text] [Related]
3. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
Elg SA; Hill RB; Heldman L; Ramakrishnan S
Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
[TBL] [Abstract][Full Text] [Related]
4. IL-2-dependent proliferation of murine T cells requires expression of both the p55 and p70 subunits of the IL-2 receptor.
Jankovic DL; Rebollo A; Kumar A; Gibert M; Thèze J
J Immunol; 1990 Dec; 145(12):4136-44. PubMed ID: 2258612
[TBL] [Abstract][Full Text] [Related]
5. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells.
Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V
Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792
[TBL] [Abstract][Full Text] [Related]
6. Induction of interleukin 2 receptor (TAC) by tumor necrosis factor in YT cells.
Lee JC; Truneh A; Smith MF; Tsang KY
J Immunol; 1987 Sep; 139(6):1935-8. PubMed ID: 2442261
[TBL] [Abstract][Full Text] [Related]
7. Release of sIL-2R alpha from and activation of native human peripheral blood mononuclear cells by recombinant IL-15.
Treiber-Held S; Stewart DM; Barraclough HA; Kurman CC; Nelson DL
Clin Immunol Immunopathol; 1996 Jul; 80(1):67-75. PubMed ID: 8674241
[TBL] [Abstract][Full Text] [Related]
8. Identification of a soluble IL-2 receptor beta-chain from human lymphoid cell line cells.
Honda M; Kitamura K; Takeshita T; Sugamura K; Tokunaga T
J Immunol; 1990 Dec; 145(12):4131-5. PubMed ID: 2258611
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin 2 receptors abrogate IL-2 induced activation of peripheral mononuclear cells.
Zorn U; Dallmann I; Grosse J; Kirchner H; Poliwoda H; Atzpodien J
Cytokine; 1994 Jul; 6(4):358-64. PubMed ID: 7948742
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the participation of interleukin-2 (IL-2) and IL-4 in the regulation of autonomous growth and tumorigenesis of transformed cells of lymphoid origin.
Hassuneh MR; Nagarkatti PS; Nagarkatti M
Blood; 1997 Jan; 89(2):610-20. PubMed ID: 9002965
[TBL] [Abstract][Full Text] [Related]
11. Cell type-specific tyrosine phosphorylation of IL-2 receptor beta chain in response to IL-2.
Kumaki S; Asao H; Takeshita T; Kurahayashi Y; Nakamura M; Beckers T; Engels JW; Sugamura K
FEBS Lett; 1992 Sep; 310(1):22-6. PubMed ID: 1526279
[TBL] [Abstract][Full Text] [Related]
12. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
13. The interleukin 2 receptor (IL-2R): the IL-2R alpha subunit alters the function of the IL-2R beta subunit to enhance IL-2 binding and signaling by mechanisms that do not require binding of IL-2 to IL-2R alpha subunit.
Grant AJ; Roessler E; Ju G; Tsudo M; Sugamura K; Waldmann TA
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2165-9. PubMed ID: 1549576
[TBL] [Abstract][Full Text] [Related]
14. AML blasts variably express interleukin 2 receptor alpha, beta or gamma chains without measurable effects on proliferation, cytokine message expression or surface expression of adhesion molecules upon stimulation with interleukin 2.
Weidmann E; Brieger J; Bergmann L; Hoelzer D; Mitrou PS
Leuk Res; 1995 Jul; 19(7):469-76. PubMed ID: 7637393
[TBL] [Abstract][Full Text] [Related]
15. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth.
Chastagner P; Moreau JL; Jacques Y; Tanaka T; Miyasaka M; Kondo M; Sugamura K; Thèze J
Eur J Immunol; 1996 Jan; 26(1):201-6. PubMed ID: 8566067
[TBL] [Abstract][Full Text] [Related]
16. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA
J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
Naume B; Gately M; Espevik T
J Immunol; 1992 Apr; 148(8):2429-36. PubMed ID: 1373169
[TBL] [Abstract][Full Text] [Related]
18. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
[TBL] [Abstract][Full Text] [Related]
19. Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling.
Arima N; Kamio M; Imada K; Hori T; Hattori T; Tsudo M; Okuma M; Uchiyama T
J Exp Med; 1992 Nov; 176(5):1265-72. PubMed ID: 1402672
[TBL] [Abstract][Full Text] [Related]
20. Regulatory mechanisms for the expression of a functional beta chain of interleukin 2 receptor on T4 chronic lymphocytic leukemia cells.
Maeda Y; Hattori T; Sakai K; Yamamura Y; Murakami T; Asou N; Tsudo M; Takatsuki K
Growth Factors; 1991; 4(4):289-95. PubMed ID: 1764265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
